News

Effective Rheumatoid Arthritis Antibody Treatment Identified From Company’s Antibody Generation Technologies and Mouse Modelling, Showcasing At UCB 08 March 2012: ModiQuest, Nijmegen, The Netherlands: Jos Raats, CEO of ModiQuest has been invited to UCB, England on March 8th to give a seminar on their novel, effective antibody-based treatments for Rheumatoid Arthritis.

30 November 2011: ModiQuest Research, Nijmegen, The Netherlands: ModiQuest Research, the full service provider for antibody generation, engineering and optimization, has been awarded the Mercator Award for best performing spin-off from the Radhoud University, UMC and the HAN. A total of sixteen companies entered into the annual competition, which provides 5000 Euro and a work … Continue reading →

ModiQuest Research Delivers Novel Rheumatoid Arthritis Therapeutic Antibodies 30 November 2011: ModiQuest Research, Nijmegen, The Netherlands: ModiQuest Research, the full service provider for antibody generation, engineering and optimization, has successfully generated novel antibody therapeutic leads and diagnostics for rheumatoid arthritis (RA). Using its extensive antibody generation technology platform, which includes phage display and high throughput … Continue reading →

Effective Rheumatoid Arthritis Antibody Treatment Identified From Company’s Antibody Generation Technologies and Mouse Modelling, Showcasing At Bayer 22 November 2011: ModiQuest Research, Nijmegen, The Netherlands: Jos Raats, CEO of ModiQuest has been invited to Bayer, Germany on 22 November to give a seminar on their novel, effective antibody-based treatments for Rheumatoid Arthritis. The discoveries were … Continue reading →

Technologies For Developing New Antibody Treatments Showcasing At Human Antibodies and Hybridomas (HAH) 2011 25 October 2011: ModiQuest Research, Nijmegen, The Netherlands: Combining accurate, early diagnostic tests for autoimmune disease, and new antibody treatment options are two themes being presented by antibody technology experts, ModiQuest Research at HAH 2011 (7-9 November 2011, Cannes, France). ModiQuest … Continue reading →

The Technology Behind The New Monoclonal Antibody Drugs: Meet ModiQuest Research At Biotechnica 2011 07 October 2011: ModiQuest Research, Nijmegen, The Netherlands: Rapid growth in the monoclonal antibodies market has been made possible by technological advances in recombinant monoclonal technologies, showcased by antibody technology experts, ModiQuest Research, at BIOTECHNICA 2011 (11-13 October, Hannover, Germany). ModiQuest … Continue reading →

ModiQuest Research Makes Antibody R&D Easier With Their New Website ModiQuest Research, Nijmegen, The Netherlands: ModiQuest Research, the antibody technology experts, announce the launch of their new website (www.modiquestresearch.com). With a fresh new look, it will save time and effort for antibody research teams worldwide. An intuitive structure, ‘quick quotes’ and fixed pricing look set … Continue reading →